共 50 条
- [33] Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia [J]. PharmacoEconomics, 2022, 40 : 807 - 821
- [35] Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (06): : 162 - 172
- [36] Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2022, 44 : 60 - 68
- [38] Accuracy Versus Impact: The Referee Verdict on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Staging of Prostate Cancer [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2021, 34 : 83 - 85